Navidea Biopharmaceuticals, Inc. (NAVBQ)

NAVBQ Revenue

Navidea Biopharmaceuticals had revenue of $610.00 in the twelve months ending September 30, 2023, down -99.47% year-over-year. In the year 2022, Navidea Biopharmaceuticals had annual revenue of $65.65K, down -87.65%. That makes Navidea Biopharmaceuticals the 47,735th largest company in the world by revenue and 7,320th in the United States.

• Revenue (ttm): 610.00
• Revenue Growth: -99.47%
• P/S Ratio: 16.39
• Revenue / Employee: 46.92
• Employees: 15
• Market Cap: 10.00K

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Europe 14.04K 95.8%
• Australia 610.00 4.2%

Fiscal year ended Dec 31, 2022

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	65.65K	-465.86K	-87.65%
Dec 31, 2021	531.51K	-383.50K	-41.91%
Dec 31, 2020	915.01K	257.19K	39.10%
Dec 31, 2019	657.83K	-511.53K	-43.74%
Dec 31, 2018	1.17M	-641.09K	-35.41%

Data Source: S&P Global Market Intelligence Last updated: Nov 14, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error